Capecitabine (Capecitabine Tablets) – Patient-Friendly Guide (UK)

Capecitabine is an oral anti-cancer medicine used to treat certain cancers, either alone or in combination with other treatments. It belongs to a group of medicines known as fluoropyrimidines.

This guide explains how capecitabine works, how it is used, what to expect, and important safety information for people in the United Kingdom. It is written in a patient-friendly style to help you understand your treatment plan.

Basic product information

• Generic name: Capecitabine
• Medicinal form: Tablets for oral use
• How it is taken: Swallowed with water, usually twice daily in defined cycles
• Medicinal category: Antimetabolite / fluoropyrimidine
• Common brand names: Brand availability varies; your pharmacist can confirm the exact product you have.

In the UK, capecitabine is supplied in tablet strengths that may differ by manufacturer. Always check your packaging for: your tablet strength, the number of tablets per dose, and the dose schedule written on your treatment plan.

How capecitabine works (mechanism of action)

Capecitabine is a “prodrug,” meaning it is converted in the body into an active anti-cancer compound. After you take it by mouth, capecitabine is processed through several steps to form 5-fluorouracil (5-FU).

The key steps are:

• Capecitabine is converted to 5’-deoxy-5-fluorocytidine (via enzymes including cytidine deaminase).
• That compound is further converted to 5-fluorouracil (5-FU).
• 5-FU interferes with how tumour cells make and repair DNA and RNA, preventing them from dividing and growing.

One reason capecitabine can be effective is that conversion to 5-FU tends to occur more in certain tumour tissues than in normal tissues, though side effects can still occur.

Pharmacokinetics (what the body does with it)

Understanding pharmacokinetics (how the body absorbs, distributes, metabolises, and clears a medicine) can help explain why timing, monitoring, and food effects matter.

• Absorption: Capecitabine is absorbed from the gut and is metabolised in the liver and other tissues.
• Activation: It is converted to active 5-FU through a series of enzymatic steps.
• Distribution: The active metabolites distribute throughout the body and can reach tumour tissue.
• Elimination: Metabolites are largely eliminated through the kidneys (urine).
• Half-life: The drug and its metabolites are cleared over several hours to about a day, but effects on cell division can last longer.

Kidney function matters: Because capecitabine metabolites are cleared by the kidneys, dose adjustments or extra monitoring may be needed if you have reduced kidney function.

Typical use in the UK (indications)

Capecitabine is used to treat several cancers. Your exact indication depends on your diagnosis, staging, and the overall plan from your oncology team.

Common indications include:

• Breast cancer: Often used in combination or in selected settings, including after surgery or when cancer has spread.
• Gastrointestinal cancers (colorectal): Used in certain stages of colorectal cancer and sometimes as part of combination regimens.
• Gastric (stomach) cancer: Used in selected treatment pathways, often in combination with other medicines.
• Other tumour types: In some circumstances, clinicians may use capecitabine where appropriate based on evidence and local protocols.

Important: Indications and combinations can vary. Always confirm what capecitabine is being used for in your particular case.

Dose and timing (how it is usually taken)

Capecitabine dosing is highly individual. It depends on: your cancer type, body surface area (often calculated from height and weight), the regimen, and your blood counts and side effects.

Your regimen may be one of several standard schedules. A commonly used pattern is:

• Twice daily dosing (morning and evening)
• Days on treatment followed by a rest period (for example, 14 days on treatment and 7 days off in a 21-day cycle; your plan may differ)

General guidance on timing

• Try to take doses at consistent times each day.
• Maintain the morning/evening separation as closely as possible (for example, roughly 12 hours apart).
• If you miss a dose, follow your local instructions or the guidance you were given by your clinical team or pharmacist.

Do not change your dose schedule without medical guidance, especially because capecitabine often requires careful adjustment based on blood results and side effects.

Food interactions and meal timing

Food can affect how capecitabine is absorbed. To reduce variability and help your body absorb the medicine consistently, capecitabine is usually taken with meals.

Typical meal-related advice:

• Take capecitabine after food (commonly after breakfast and after dinner).
• Do not take it on a completely empty stomach unless your healthcare professional specifically instructs otherwise.

If you have nausea, appetite changes, vomiting, or feeding difficulties, discuss it promptly with your care team. They can advise on the best approach to keep dosing consistent.

Alcohol and medicine interactions

Alcohol

There is no single universal rule that everyone must avoid alcohol completely while taking capecitabine, but alcohol may increase risk of side effects such as:

• Nausea or stomach irritation
• Fatigue
• Dehydration (which can be particularly important if you develop diarrhoea)

In practice, many oncology teams advise limiting alcohol or avoiding it during treatment, especially if you are experiencing side effects. Ask your clinician or pharmacist what is safest for you.

Other medicines and interactions

Capecitabine can interact with other medicines, affecting either capecitabine levels or side effect risk. Always tell your pharmacist and oncologist about everything you take, including over-the-counter products and herbal supplements.

Examples of medicines that may interact:

• Warfarin (and other vitamin K antagonists): can increase the risk of bleeding. Close monitoring may be needed.
• Phenytoin: may have altered levels leading to toxicity or reduced effectiveness.
• Folinic acid / leucovorin: may be used in combinations and can affect treatment effect and side effects.
• Allopurinol: may affect metabolism.
• Medicines that affect liver enzymes or kidney function: can change clearance and exposure.
• Antacids: Some preparations may affect absorption or tolerability (your pharmacist can advise).

If you start or stop any medicine during treatment (including antibiotics, antifungals, and painkillers), check with your pharmacist before doing so.

Safety profile: common and serious side effects

Like all medicines, capecitabine can cause side effects. Many are manageable, especially when recognised early. Your team may monitor your blood counts and organ function and may adjust or pause treatment if side effects occur.

Common side effects

• Diarrhoea (sometimes severe; prompt reporting is important)
• Nausea and/or vomiting
• Loss of appetite
• Fatigue
• Mouth sores (stomatitis)
• Hand-foot syndrome (palmar-plantar erythrodysesthesia): redness, swelling, pain, or blistering on palms and soles
• Abdominal discomfort
• Hair thinning (varies by regimen)

Less common but important side effects

• Low blood counts: increased risk of infection (neutropenia), anaemia (tiredness), or bleeding/bruising (thrombocytopenia)
• Rash or skin changes
• Liver enzyme changes seen on blood tests
• Kidney function changes, especially if dehydrated from diarrhoea

Serious side effects – seek urgent medical help

Contact your urgent care service or seek immediate advice if you experience signs of severe reaction, such as:

• Severe diarrhoea or diarrhoea lasting more than a short period, particularly with weakness or dizziness
• Fever (for example, a temperature of 38°C or higher) especially if your blood counts may be low
• Signs of infection (shivering, feeling very unwell)
• Severe mouth sores preventing eating or drinking
• Chest pain, severe shortness of breath, or sudden swelling
• Severe hand-foot reactions affecting walking or using your hands

If you are unsure how urgently to seek help, contact NHS 111 for advice (or your cancer team if you have direct contact arrangements).

Practical use tips for better tolerability

Plan ahead for hand-foot syndrome

• Keep hands and feet moisturised using fragrance-free creams.
• Avoid friction, tight shoes, and prolonged pressure on soles.
• Let your team know early if you notice tingling, redness, or soreness.
• Do not use new skin products without checking first.

Manage diarrhoea early

• Report any diarrhoea quickly; early intervention is key.
• Focus on hydration (small frequent sips can help).
• Ask your team which anti-diarrhoea medicine you should use and when.
• Avoid dehydration, which can worsen kidney stress.

Support mouth health

• Use gentle oral care (soft toothbrush, mild rinses if recommended).
• Tell your team if you develop sores so they can advise targeted treatment.
• Choose foods that are soft and easy to swallow if your mouth is sore.

Nutrition and hydration

• Try to maintain adequate fluid intake, especially if you have nausea or diarrhoea.
• Small meals may be easier than large ones.
• Seek dietetic support early if weight loss or poor intake becomes an issue.

Keep a simple treatment diary

• Record dose times and any missed doses.
• Track side effects (timing, severity, and triggers).
• This helps your oncology team adjust treatment promptly and safely.

Adjustments, monitoring, and what to expect during treatment

Capecitabine treatment typically involves regular monitoring. This may include:

• Blood tests: checking white blood cells, neutrophils, platelets, and liver function
• Kidney function tests: especially if you have diarrhoea, dehydration, or existing kidney issues
• Assessment of side effects: including hand-foot syndrome and diarrhoea severity

If side effects occur, clinicians may adjust:

• Dose (reduce the amount per dose)
• Schedule (delay or pause treatment)
• Supportive medicines (for symptom control)

Alternative options (discuss with your oncology team)

Treatment for cancer depends on cancer type, stage, prior therapies, and overall health. Alternatives to capecitabine may include:

• Other oral fluoropyrimidines (depending on availability and your regimen)
• 5-fluorouracil (5-FU) given by injection or infusion (often in combination with other agents)
• Other chemotherapy drugs such as oxaliplatin- or irinotecan-based combinations (for colorectal cancers, for example)
• Targeted therapies or immunotherapies where appropriate, based on tumour markers
• Radiotherapy and combination multimodal approaches in certain settings

Ask your clinician what options are suitable for your cancer type and what benefits and risks differ from capecitabine.

UK market and legal context (what to know as a patient)

In the United Kingdom, medicines are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and must be used in line with the medicine’s licensed information. Cancer medicines are supplied through healthcare services and approved supply chains, and patient eligibility depends on the treatment plan.

Availability can vary by region and by pack size. Your local pharmacy can advise on expected lead times, and many oncology medicines are provided through established pathways to support safe dispensing and monitoring.

If you are purchasing through an online pharmacy, the correct product and pack strength should match what your healthcare team has planned, and you should receive clear information on: dose instructions, tablet strength, cycle schedule, and storage.

Recent guidance (how care has been evolving)

Guidance for fluoropyrimidine medicines like capecitabine continues to emphasise:

• Prompt toxicity management (especially diarrhoea and hand-foot syndrome)
• Early reporting of symptoms so dose modifications can be made quickly
• Monitoring of kidney function and hydration status
• Medication review for interactions, particularly blood-thinning medicines and drugs affecting metabolism

UK cancer care commonly follows national oncology pathways and clinician-led protocols that may be updated as new evidence and safety information becomes available. Your oncology team will apply the most relevant guidance for your regimen.

Delivery and availability (UK)

Online pharmacy availability depends on stock, supplier lead times, and the correct pack strength required. For cancer medicines, accurate supply is especially important.

Typical steps you can expect:

• Confirm the tablet strength and pack size shown on your treatment instructions.
• Place your order with correct details and address for delivery within the UK.
• Allow for processing and dispatch time. Dispatch may be earlier or later depending on stock status.
• Follow storage guidance on the pack (often stored at room temperature away from moisture and direct sunlight).

If you need help choosing the correct pack or have concerns about lead time, contact the pharmacy customer support team before placing the order.

Storage and handling

• Store tablets in the original packaging as directed on the box.
• Keep out of sight and reach of children.
• Do not use tablets after the expiry date printed on the pack.
• Check for any specific storage instructions on your product label.

FAQ – Capecitabine

1) What is capecitabine used for?

Capecitabine is used to treat certain cancers, including some types of breast cancer, colorectal cancer, and gastric (stomach) cancer, either alone or in combination with other medicines, depending on the cancer type and stage.

2) How do I take capecitabine?

It is usually taken by mouth after food (commonly after breakfast and after dinner). Doses are taken twice daily on a set schedule in cycles. Follow your dose plan exactly.

3) Why does food matter?

Food can improve absorption and reduce variability. Taking capecitabine after meals helps ensure more consistent exposure and may reduce stomach-related side effects.

4) What should I do if I miss a dose?

Missed doses should be handled carefully. Follow the advice given by your oncology team or pharmacist. Do not double up to make up for a missed dose unless specifically instructed.

5) What are the warning signs that mean I should contact my care team urgently?

Contact your cancer team urgently (or seek urgent medical advice) if you have severe diarrhoea, fever (often 38°C or higher), signs of infection, severe hand-foot syndrome, or dehydration (for example, feeling faint or unable to keep fluids down).

6) Can I drink alcohol during treatment?

Many people are advised to limit alcohol or avoid it, especially if they experience nausea, diarrhoea, or dehydration. Ask your clinician or pharmacist what’s safest for you.

7) What interactions should I be particularly careful about?

Tell your pharmacist if you take warfarin or other blood thinners, phenytoin, allopurinol, or any regular over-the-counter or herbal products. Interactions may affect bleeding risk, drug levels, or side effect severity.

8) Will capecitabine cause hair loss?

Hair thinning can occur for some people, but it varies by regimen and individual response. Your oncology team can provide expectations for your combination plan.

9) How will my kidney function be managed?

Blood tests may be used to monitor kidney function. If you develop diarrhoea or dehydration, it’s especially important to report it quickly so hydration can be supported and dosing decisions can be made safely.

10) Are there alternatives if I cannot tolerate capecitabine?

Yes. Depending on your cancer and previous treatments, alternatives may include other chemotherapy regimens, different fluoropyrimidine schedules, targeted therapy, immunotherapy, or supportive care strategies. Discuss options with your oncology team.

Summary

Capecitabine is an oral chemotherapy medicine that is converted in the body into an active form that helps stop cancer cells from growing. In the UK, it is commonly used for selected cancers such as breast, colorectal, and stomach cancers, often as part of standard regimens.

Success and safety depend on taking it on schedule, after meals, and reporting side effects early, especially diarrhoea and hand-foot syndrome. Regular monitoring through blood tests supports safe dosing and timely adjustments when needed.

If you have questions about your specific regimen, side effects, or interactions with other medicines, speak to your oncology team or pharmacist.